Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

NCT04965051 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus With Diabetic Gastroparesis
HbA1c
Time in Range

Interventions

DRUG: insulin degludec/insulin aspart (IDegAsp)
DRUG: basal insulin plus pre-prandial insulin

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University